Current Research:

CagriSema is a combination therapy that includes Cagrilintide, an amylin analog, and Semaglutide. Amylin is a hormone co-secreted with insulin that helps regulate glucose levels and suppress appetite. Cagrilintide mimics amylin’s effects, enhancing satiety and reducing food intake. By combining Cagrilintide with Semaglutide, CagriSema, researchers aim to provide a more rapid and comprehensive approach to menopausal fat belly loss by targeting multiple pathways involved in appetite regulation and glucose metabolism.

Each CagriSema  kit contains: 
4-10mg CagriSema research peptide
4- 10 mL Bacteriostatic purified water
4-18G Mixing Luer Lock Needles
4-30-G/13mm Luer loc injection needles
4-5ml luer loc syringe
10 alcohol cleansing pads

Dosing: When 10mg of peptide is reconstituted with 10 mL of bacteriostatic water, the dosing will be 1mg/mL. Filling the 5ml syringe with reconstituted peptide is 5mg. Store in the refrigerator. This item ships in ice medium.

All products are for laboratory research purposes only, not for human consumption, medical, or veterinary use. Amwiner Peptides does not condone or support the use of peptides outside of controlled scientific research. By purchasing, you acknowledge that you are a qualified researcher or institution. You must be 21 or older.

 Contact us for the COA.